Skip to content

Eledon Pharmaceuticals, Inc.

ELDN

CIK 0001404281

← back to feed
Revenue (TTM)
$0
Q1 May 2026
Net Income (TTM)
−$74.2M
−26.1% YoY Q1 May 2026
EPS Diluted (TTM)
−$0.75
+21.2% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$57.35M
Q1 May 2026
Cash
$6.15M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
77.19M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings